Samuraciclib Uses, Dosage, Side Effects and more
Samuraciclib is under investigation in clinical trial NCT03363893 (Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies).
| Attribute | Details |
|---|---|
| Trade Name | Samuraciclib |
| Generic | Samuraciclib |
| Samuraciclib Other Names | Samuraciclib |
| Type | |
| Formula | C22H30N6O |
| Weight | Average: 394.523 Monoisotopic: 394.24810961 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
